ENTITY
Biotest AG

Biotest AG (BIO GR)

15
Analysis
Health Care • Germany
Biotest AG is a provider of plasma proteins and biological drugs. The Company has specialized primarily in the areas of clinical immunology, haematology and intensive medicine with a focus on treating diseases of the immune and haematopoietic systems. Biotest AG has production operations mainly in Europe and the US, and sells its products worldwide.
more
bullish•Grifols SA
•03 Apr 2025 05:30

Blood, Sweat, and Bids: Grifols Draws Renewed Interest from Brookfield

​Brookfield's renewed interest in Grifols signals confidence in its turnaround, with strengthened financials and potential for improved future...

Share
bullish•Nordex SE
•21 Jul 2022 18:59

DAX/​MDAX/​SDAX Quiddity Leaderboard Sep 2022: Some Changes for SDAX and MDAX

Hochtief AG and Hella GmbH could move from SDAX to MDAX and Grand City Properties and Uniper SE could move from MDAX to SDAX. There could be 2...

Share
bearish•Investor
•20 Jul 2022 04:51

Liquid Universe of European Ordinary and Preferred Shares: July ‘22 Report

There has not been a clear trend regarding premiums and discounts across our liquid universe since mid June. I highlight the widening discounts in...

Share
bearish•Sixt SE
•17 Jun 2022 06:55

Liquid Universe of European Ordinary and Preferred Shares: June ‘22 Report

For the most part since mid-May, spreads were compressing, but inflation fears and rate rises have hit hard the stock markets in the last trading...

Share
•23 May 2022 22:37

Liquid Universe of European Ordinary and Preferred Shares: May '22 Report

Spreads have generally tightened across our liquid universe, in line with the recent market gains. Schroders announced a share class unification.

Share
x